The human genome is made up of 3 billion letters of DNA (A, T, C and G). Whole genome sequencing is a technique that is used to ‘read’ these letters and finds their order one by one. The digital ...

A “world-first” surveillance program will use rapid diagnostic technology from a private genomics company to identify and monitor potential outbreaks of bacterial or viral diseases. The U.K.

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY) today announced an agreement with Genomics England to further collaborate on the Generation Study. Under the new contract, Revvity will now ...

Revvity (RVTY) announced an expansion of its work with Genomics England that leverages both organizations’ expertise and resources to advance critical genomic initiatives across the United Kingdom.

Ana Lisa Tavares, Clinical Lead for Rare Disease Research at Genomics England, shares her thoughts on the 'hype and hope' ...

Job Description Key responsibilities Working collaboratively with the Participant Panel Chair and Vice-Chair for Rare Conditions: Help to shape ...

QIAGEN N.V. QGEN recently partnered with Genomics England to support the delivery of the Generation Study. QIAGEN’s Clinical Knowledge Base will power a first-of-its-kind whole-genome sequencing study ...

New agreement to support newborn health adds sequencing lab services to the existing extraction services collaboration The Generation Study, a research project spearheaded by Genomics England in ...

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced an expansion of its work with Genomics England that leverages both organizations' expertise and resources to advance ...